Filing Details
- Accession Number:
- 0001645627-17-000055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-08 15:29:08
- Reporting Period:
- 2017-05-04
- Filing Date:
- 2017-05-08
- Accepted Time:
- 2017-05-08 15:29:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Transaction Summary
| Purchased: | 23,000 shares | Avg. Price: $0.08 | Total Value: $1,736.90 |
| Number of Shares After Transactions: | 20,651,949 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,629,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,630,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,631,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,632,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,633,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,634,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,635,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,636,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,637,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,638,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,639,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,640,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,641,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,642,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,643,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,644,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,645,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,646,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,647,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,648,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,649,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.08 | 20,650,949 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-04 | 1,000 | $0.07 | 20,651,949 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
